Surgical Science Sweden AB (publ) (SUS.ST)

SEK 154.5

(0.85%)

Market Cap (In SEK)

7.88 Billion

Revenue (In SEK)

882.85 Million

Net Income (In SEK)

233.97 Million

Avg. Volume

100.26 Thousand

Currency
SEK
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
111.8-196.9
PE
-
EPS
-
Beta Value
0.973
ISIN
SE0014428512
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Mr. Gisli Hennermark
Employee Count
-
Website
https://www.surgicalscience.com
Ipo Date
2017-06-19
Details
Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence-based laparoscopic and endoscopic training. It offers LapSim training system comprising LapSim ST develops to train surgical technologists and surgical assistants; and LapSim essence, a portable and ready-to-use VR simulator. The company also provides EndoSim system, an endoscopy simulator that delivers medical simulation training; TeamSim, a dynamic platform for inter-professional education development taking surgery simulation into the real world teamwork; Simball Box, which offers feedback on velocity with tutorial task videos showing a preferred approach; simbionix simulators; and robotic surgery simulators. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden.